PROABTECH
ProAbTech is a research and development company that develops conjugated biological drugs.
PROABTECH
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Gwangju, Kwangju-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.proabtech.com
Total Employee:
11+
Status:
Active
Contact:
+82 062 971 0917
Total Funding:
10 B KRW
Technology used in webpage:
South Korean Server Location
Similar Organizations
Aimble
Aimble is an AI drug development company that offers drugs to treat intractable diseases.
April Bio
April Bio is a drug development company that develops antibodies and long-acting biologics.
Haihe Biopharma
Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.
Toll Biotech
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets.
Ubix Therapeutics
Ubix Therapeutics is a research and development company that develops anti-cancer drugs.
Yiran Biotechnology
Yiran Biotechnology is a research and development company that produces lactic acid bacteria and probiotic products.
Investors List
Kumoh Electronics
Kumoh Electronics investment in Series A - ProAbTech
Hana Financial Investment
Hana Financial Investment investment in Series A - ProAbTech
HYK Partners
HYK Partners investment in Series A - ProAbTech
Golden Oak
Golden Oak investment in Series A - ProAbTech
Albatross Investment
Albatross Investment investment in Series A - ProAbTech
Hanwha Investment & Securities
Hanwha Investment & Securities investment in Series A - ProAbTech
Widwin Investment
Widwin Investment investment in Series A - ProAbTech
TIPS Program
TIPS Program investment in Pre Seed Round - ProAbTech
Official Site Inspections
http://www.proabtech.com Semrush global rank: 11.54 M Semrush visits lastest month: 156
- Host name: 203.245.24.30
- IP address: 203.245.24.30
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ProAbTech"
ProAbTech - Crunchbase Company Profile & Funding
Organization. ProAbTech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ProAbTech โฆSee details»
ProAbTech
ํ๋ก์ฑํ์ ๊ณ ํต๋ฐ๋ ํ์๋ค์๊ฒ ์๋ก์ด ์น๋ฃ๊ธฐํ์ ์ ๊ณต์ผ๋ก ์ถ์ด ๋์ฑ ํ์๋ก์์ง๊ธธ ์๋งํฉ๋๋ค.See details»
ProAbTech - Funding, Financials, Valuation & Investors - Crunchbase
ProAbTech is a research and development company that develops conjugated biological drugs. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much โฆSee details»
ProAbtech Company Profile 2024: Valuation, Funding & Investors
ProAbtech General Information Description. Developer of biopharmaceutical company with a novel technology designed to develop biopharmaceuticals with improved efficacy and stability โฆSee details»
ProAbtech Co., Ltd. - VentureRadar
ProAbTech is a pioneering biopharmaceutical company dedicated to enhancing human welfare by developing next-generation bio-conjugates. Specializing in therapeutic proteins, peptides, and โฆSee details»
ProAbTech - Products, Competitors, Financials, Employees, โฆ
ProAbTech was founded in 2017. Where is ProAbTech's headquarters? ProAbTech's headquarters is located at 123, Cheomdanggwagi-ro, Buk-gu, Gwangju. What is ProAbTech's โฆSee details»
ProAbTech - Company Profile - Tracxn
Nov 27, 2024 Eternal Blue-United States based, 2017 founded, Unfunded company; Golden Cube-Dubai based, 2022 founded, Unfunded company; Hpt.ee-Estonia based, 2014 founded,. โฆSee details»
ProAbTech - Crunchbase
ProAbTech is a research and development company that develops conjugated biological drugs.See details»
ProAbTech - Raised Funding from 1 investor - Tracxn
Nov 16, 2024 ProAbTech funding & investors. Provider of end-to-services for the development of biological drugs. 2017 โข Gwangju (South Korea) โข Funding RaisedSee details»
ProAbTech Stock Price, Funding, Valuation, Revenue ... - CB Insights
Feb 22, 2024 ProAbTech has raised $10.85M over 4 rounds. ProAbTech's latest funding round was a Series A - II for $2.26M on February 22, 2024. Date. Round. Amount. Investors. โฆSee details»
R&D ProAbTech - CELLAbeauti
Research and development company specializing in biopharmaceuticals. It is a specialized research and development company that develops . long-acting biopharmaceuticals with improved efficacy and stability in the body than โฆSee details»
ProAbTech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 Organization. ProAbTech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 3. Monthly โฆSee details»
JEONG HAENG CHO๋ - CEO - ProAbtech Co. Ltd. - LinkedIn
Better Biologocal Drugs · ๊ธ๋ก๋ฒ ์ ์ฝ๊ฐ๋ฐ ํธ๋ ๋๋ ์ผ๋ฐ์ ์ผ๋ก ๋ฐ์ด์ค์์ฝํ์ด ํฉ์ฑ์์ฝํ ๋๋น<br>์ฝํจ๊ฐ ์ฐ์ํ๊ณ ๋ถ์์ฉ์ด ์ ์ผ๋ฉฐ ์์ ์ฑ๊ณต๊ฐ๋ฅ์ฑ์ด ๋์ โฆSee details»
KYUNGHEE LEE - Head Of R&D - ProAbTech Co. Ltd | LinkedIn
PhD/Head of R&D at ProAbTech Co Ltd · Experience: ProAbTech Co. Ltd · Education: Yonsei University · Location: Seoul Incheon Metropolitan Area · 73 connections on LinkedIn. โฆSee details»
PAT-202 - Drug Targets, Indications, Patents - Synapse - Patsnap
PAT-202, Initially developed by ProAbTech Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Endocrinology and Metabolic Disease, Active ...See details»
Series A - ProAbTech - 2020-08-10 - Crunchbase
Organization Name . ProAbTech . Announced Date Aug 10, 2020; Funding Type ...See details»
PAT-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Now, its global highest R&D status is Phase 1, Mechanism: Urate oxidases replacements, Therapeutic Areas: Congenital Disorders,Endocrinology and Metabolic โฆSee details»
PAT-101, a new recombinant human albumin-conjugated urate
Jan 15, 2024 Proabtech Co. Ltd. investigators have published findings from the preclinical characterization of PAT-101, a novel recombinant human albumin (rHA)-conjugated urate โฆSee details»
PAT-103 - Drug Targets, Indications, Patents - Synapse - Patsnap
Accelerate Strategic R&D decision making with Synapse, PatSnapโs AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.See details»
Series A - ProAbTech - 2021-10-25 - Crunchbase
Oct 25, 2021 Organization Name . ProAbTech . Announced Date Oct 25, 2021; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. โฆSee details»